Skip to main content
Spin-off

MOAB

Year of incorporation

2019

Field

Biotechnology and Bioengineering.

Activity

Manufacture and marketing of MOAB, the first miniaturized millifluidic bioreactor equipped with three optically accessible culture chambers able to contain, under continuous perfusion, Scaffold or other three-dimensional structures essential for the creation of in vitro human organ models (organoids).

Services

MOAB technology allows to:

  • Perform safety tests for Biopharmaceuticals and Therapies
  • Studying cell cultures over time under continuous perfusion
  • Live Imaging of Organoids 

Target Market

  • Bioreactors and devices for cell cultures
  • Testing device for Therapies and Biopharmaceuticals